Cafepharma Today

May 20 2025 - FDA outlines stricter Covid vaccine booster approval standards for healthy people
FDA outlines stricter Covid vaccine booster approval standards for healthy people
AHA warns tariffs could worsen drug shortages, pushes for long-term reform
Surveyed via text, HCPs say they want more interactions with pharma
Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

This Week in Biotech
Motley Fool
Sunday, December 22, 2013 - 12:28pm
tags:
GSK, Theravance, Ariad Pharmaceuticals, Gilead Sciences, AbbVie, Cubist Pharmaceuticals, Jazz Pharmaceuticals, Gentium
Merck's Pursuit Of Weight-Loss Business Is Savvy, Not Stupid
Forbes
Saturday, December 21, 2013 - 11:49am
tags:
Merck, weight loss, obesity
Merck issues voluntary recall on Gardasil vaccine
CNBC
Saturday, December 21, 2013 - 11:46am
tags:
Merck, Gardasil, recalls
Pfizer's Expiring Viagra Patent Adversely Affects Other Drugmakers Too
Forbes
Saturday, December 21, 2013 - 11:45am
tags:
Pfizer, Viagra, Eli Lilly, erectile dysfunction, Bayer, Levitra, Cialis
Not-So-Solid Data Might Be Good Enough for Vertex
Motley Fool
Saturday, December 21, 2013 - 11:37am
tags:
Vertex Pharmaceuticals, Kalydeco, cystic fibrosis
Biota Reports That Laninamivir Octanoate is Approved for the Prevention of Influenza in Japan
Yahoo/Globe Newswire
Saturday, December 21, 2013 - 11:34am
tags:
Biota Pharmaceuticals, Inavir, influenza
InterMune: Esbriet And Ascend Will Drive Growth
Seeking Alpha
Saturday, December 21, 2013 - 11:32am
tags:
InterMune, Esbriet, idiopathic pulmonary fibrosis
7 Things To Consider Before Investing In Biotechnology Stocks
Forbes
Saturday, December 21, 2013 - 11:31am
tags:
Update on BioLineRx's BL-7010
Yahoo/Zacks
Saturday, December 21, 2013 - 11:30am
tags:
BioLineRx, BL-7010, celiac disease
Jazz Pharma shares soar to all-time high price
Yahoo/AP
Saturday, December 21, 2013 - 11:28am
tags:
Jazz Pharmaceuticals
Why Ariad Pharmaceuticals is Soaring
The Street
Saturday, December 21, 2013 - 11:27am
tags:
Ariad Pharmaceuticals
Arena: Weekly Belviq Lower During Holidays
Seeking Alpha
Friday, December 20, 2013 - 1:06pm
tags:
Arena Pharmaceuticals, Belviq
2 Big Biotechs Moving Up On News
Seeking Alpha
Friday, December 20, 2013 - 12:58pm
tags:
Jazz Pharmaceuticals, Gilead Sciences
Sanofi faces U.S. class action over MS drug Lemtrada
Reuters
Friday, December 20, 2013 - 11:58am
tags:
Sanofi, MS, multiple sclerosis, Lemtrada
Merck Fined $21M By French Regulators For Bad Behavior
Pharmalot
Friday, December 20, 2013 - 11:55am
tags:
France, Merck, Schering Plough
Amarin's Anchor Gamble Sends Stock Up 20% On 'No News' News
Seeking Alpha
Friday, December 20, 2013 - 11:52am
tags:
Amarin, Vascepa, FDA
Merck Announces Launch of a New Business Focused on Comprehensive, Evidence-Based Weight Management Interventions in the U.S.
Marketwatch
Friday, December 20, 2013 - 11:50am
tags:
obesity, weight loss, Merck
Inovio CEO Interview: PD1/PDL1 Inhibitors, Immunotherapy And Why Investors Should Be Excited About 2014
Seeking Alpha
Friday, December 20, 2013 - 11:49am
tags:
Inovio, Pharma CEOs, PDL-1, immunotherapy, Joseph Kim, Bristol-Myers Squibb, Roche, Dendreon, GSK, ImmunoCellular Therapeutics, Merck, Northwest Biotherapeutics
Intrexon to Acquire Medistem to Generate Multipotent Cells
Yahoo
Friday, December 20, 2013 - 11:45am
tags:
Intrexon, MediStem, M&A
Ariad says FDA OKs marketing of Iclusig after adding new safety warnings
Yahoo/AP
Friday, December 20, 2013 - 11:35am
tags:
Ariad Pharmaceuticals, FDA, Iclusig, warnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.